We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
2751
DELISTED
Yellow Corporation Common Stock
YELL
| $312K | ﹤0.01% |
55,282
+841
| +2% | +$4.88K |
|
|
CURO
2752
DELISTED
CURO Group Holdings Corp.
CURO
| $310K | ﹤0.01% |
17,915
+975
| +6% | +$16K |
|
2753
Distribution Solutions Group
DSGR
$1.61B
| $309K | ﹤0.01% |
12,344
+382
| +3% | +$10K |
|
2754
OneWater Marine
ONEW
$201M
| $308K | ﹤0.01% |
7,656
+462
| +6% | +$19.4K |
|
|
APLT
2755
DELISTED
Applied Therapeutics
APLT
| $306K | ﹤0.01% |
18,436
+825
| +5% | +$14.2K |
|
2756
Coastal Financial
CCB
$693M
| $306K | ﹤0.01% |
9,617
+511
| +6% | +$15.2K |
|
2757
Instil Bio
TIL
$50.3M
| $305K | ﹤0.01% |
852
+50
| +6% | +$18.7K |
|
2758
Zevra Therapeutics
ZVRA
$686M
| $305K | ﹤0.01% |
32,725
+893
| +3% | +$9K |
|
2759
Greenlight Captial
GLRE
$506M
| $304K | ﹤0.01% |
41,142
+864
| +2% | +$7.21K |
|
|
FUV
2760
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $304K | ﹤0.01% |
1,332
+64
| +5% | +$17.4K |
|
2761
Mid Penn Bancorp
MPB
$952M
| $303K | ﹤0.01% |
11,011
+684
| +7% | +$18.3K |
|
|
CNBKA
2762
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $302K | ﹤0.01% |
2,622
-1,262
| -32% | -$144K |
|
2763
Blue Ridge Bankshares
BRBS
$332M
| $300K | ﹤0.01% |
17,030
+1,238
| +8% | +$21.6K |
|
2764
Pulse Biosciences
PLSE
$3.02B
| $300K | ﹤0.01% |
13,893
+593
| +4% | +$12.8K |
|
2765
Lineage Cell Therapeutics
LCTX
$278M
| $299K | ﹤0.01% |
118,723
+6,208
| +6% | +$15.9K |
|
2766
TETRA Technologies
TTI
$1.26B
| $299K | ﹤0.01% |
95,965
+20,434
| +27% | +$65.6K |
|
|
SYRS
2767
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $298K | ﹤0.01% |
6,677
+205
| +3% | +$10K |
|
|
HMTV
2768
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $296K | ﹤0.01% |
24,307
-335
| -1% | -$4.08K |
|
2769
Amalgamated Financial
AMAL
$1.49B
| $295K | ﹤0.01% |
18,678
-89
| -0.5% | -$1.36K |
|
|
IAS
2770
DELISTED
Integral Ad Science
IAS
| $294K | ﹤0.01% |
+14,245
| New | +$281K |
|
2771
HF Foods Group
HFFG
$83.4M
| $293K | ﹤0.01% |
48,389
+268
| +0.6% | +$1.49K |
|
|
NAGE
2772
Niagen Bioscience
NAGE
$247M
| $293K | ﹤0.01% |
46,755
+1,650
| +4% | +$13.6K |
|
|
EMKR
2773
DELISTED
Emcore Corp
EMKR
| $292K | ﹤0.01% |
3,899
+68
| +2% | +$5.44K |
|
|
AGS
2774
DELISTED
PlayAGS
AGS
| $291K | ﹤0.01% |
36,989
-642
| -2% | -$5.1K |
|
2775
Kopin
KOPN
$791M
| $291K | ﹤0.01% |
56,768
+3,111
| +6% | +$18.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.